Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Barr COO leaves

This article was originally published in The Tan Sheet

Executive Summary

Barr Phamaceuticals' President and Chief Operating Officer Paul M. Bisaro announces Aug. 2 he is leaving the company to work for Watson Pharmaceuticals. Barr's Chairman and CEO Bruce L. Downey will assume Bisaro's responsibilities in the interim period. The Woodcliff Lake, N.J.-based firm says it is "confident that the departure will not have a negative effect on U.S. or international operations"...

You may also be interested in...



Biden Extends Helping Hand To Small US Manufacturers, Vendors With ‘Made In America’ EO

The president’s executive order aims to give smaller companies a leg up over foreign competitors, among other objectives.

Warning Letter Roundup & Recap – 26 January 2021

No device-related warning letters were released by the US FDA the week of 26 January.

EU Crunch Time For Two Drugs That Lost Their Fast-Track Status

Karyopharm and GSK should soon learn whether the European Medicines Agency will recommend EU approval for their respective products, selinexor and dostarlimab.

Topics

UsernamePublicRestriction

Register

LL1135544

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel